Significant partial seizure reduction for pediatric patients still experiencing seizures with other antiepileptic drugs Reduction in frequency of partial seizures with TRILEPTAL adjunctive therapy1,2

Adult Efficacy Pediatric Efficacy First-line Use TRILEPTAL vs CBZ

	Results achieved with a mean TRILEPTAL dosage of 30.0 mg/kg/day (range of 6.4 to 51.4 mg/kg/day)1
	Prior to the addition of TRILEPTAL, patients were taking3 —Carbamazepine (49%) —Valproate (20%) —Lamotrigine (19%) —Phenytoin (16%)

References:

1.		Data on file. Novartis Pharmaceuticals Corporation, East Hanover, NJ.
2.		Guerreiro MM, Vigonius U, Pohlmann H, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27:205-213.
3.		Glauser TA, Nigro M, Sachdeo R, et al, and the Oxcarbazepine Pediatric Study Group. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology. 2000;54:2237-2244.